Excelsior Medical

TPE-4104
Taiwan Stock Exchange
Healthcare Medical Distribution
Global Rank
#14262
Country Rank
#457
Market Cap
475.02 M
Price
2.91
Change (%)
0.47%
Volume
45,309

Excelsior Medical's latest marketcap:

475.02 M

As of 06/26/2025, Excelsior Medical's market capitalization has reached $475.02 M. According to our data, Excelsior Medical is the 14262th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 475.02 M
Revenue (ttm) 296.75 M
Net Income (ttm) 26.82 M
Shares Out 163.4 M
EPS (ttm) 0.16
Forward PE 0.00
Ex-Dividend Date 04/24/2025
Earnings Date 08/08/2025
Market Cap Chart
Data Updated: 06/26/2025

Excelsior Medical's yearly market capitalization.

Excelsior Medical has seen its market value drop from NT$5.79 B to NT$475.02 M since 2014, representing a total decrease of 91.80% and an annual compound decline rate (CAGR) of 21.22%.
Date Market Cap Change (%) Global Rank
06/26/2025 NT$475.02 M -2.21% 14262
12/31/2024 NT$14.05 B 2.15% 14008
12/29/2023 NT$13.76 B 37.31% 13759
12/30/2022 NT$10.02 B 23.23% 14982
12/30/2021 NT$8.13 B 2.67% 16607
12/31/2020 NT$7.92 B 14.64% 14919
12/31/2019 NT$6.91 B 17.17% 14090
12/28/2018 NT$5.89 B 2.76% 14109
12/29/2017 NT$5.74 B -0.52% 14783
12/30/2016 NT$5.77 B -2.89% 13313

Company Profile

About Excelsior Medical Co., Ltd.

Excelsior Medical Co., Ltd. is a leading provider of medical solutions, serving Taiwan, Hong Kong, the Philippines, and Malaysia since its establishment in 1988. Headquartered in New Taipei City, Taiwan, the company specializes in the distribution of high-quality medical products and services.

Core Offerings

  • Medical Supplies & Equipment: Comprehensive range for healthcare facilities.
  • Medicines & Home Medical Devices: Solutions for patient care and home use.
  • Specialized Products: Hemodialysis/plasma exchange equipment, blood bags, artificial stoma products, and scar care solutions.
  • Health Appliances: Innovative devices to support wellness.

Diversified Business Operations

Beyond medical distribution, Excelsior Medical Co., Ltd. engages in:

  • Investment activities
  • Real estate ventures
  • Leasing services
  • Precision instrument sales

Frequently Asked Questions

  • What is Excelsior Medical's (TPE-4104) current market cap?
    As of 06/26/2025, Excelsior Medical (including the parent company, if applicable) has an estimated market capitalization of $475.02 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Excelsior Medical global market capitalization ranking is approximately 14262 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.